Clay Rowland is an Investment Associate at Mission BioCapital in San Francisco, supporting new investments in therapeutics companies. He joined the firm in 2025, previously working at the T1D Fund and Syros Pharmaceuticals.
At firms with a similar stage, sector and check size.
One email when Clay's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckClay Rowland is an Investment Associate at Mission BioCapital in San Francisco, supporting new investments in therapeutics companies. He joined the firm in 2025, previously working at the T1D Fund and Syros Pharmaceuticals.
Clay Rowland invests through Mission BioCapital, which writes checks of $25K to $10M at pre-seed, seed, series a.
Email [email protected], the firm's inbox for founders, and name Clay in the subject. A warm intro from a founder Mission BioCapital backed works better.
consulting at Artisan Healthcare Consulting; corporate development at Syros Pharmaceuticals; Associate at T1D Fund.
Last updated 2026-10-15. Is this you? Ask for a correction.